} clin oncol markman m intraperitoneal antineoplastic drug delivery rationale and results lancet prednisolone beta glucan oncol markman m prednisolone beta glucan intraperitoneal hyperthermic chemotherapy as prednisolone beta glucan treatment of peritoneal carcinomatosis of colorectal cancer j clin oncol author reply conti m, de giorgi u, tazzari v, bezzi vitex prozac danger f and baccini � clinical prednisolone beta glucan pharmacology of intraperitoneal cisplatinbased chemotherapy j chemother suppl parker rj, hartman kd and sieber sm lymphatic absorption prednisolone beta glucan and tissue disposition of liposomeentrapped prednisolone beta glucan [c]adriamycin following intraperitoneal administration to rats cancer res parker rj, priester er and sieber sm comparison of lymphatic uptake, metabolism, prednisolone beta glucan excretion, and biodistribution of free and liposomeentrapped [c]cytosine betadarabinofuranoside following intraperitoneal administration prednisolone beta glucan to rats drug metab dispos side ffects of discontinuing desyrel rosa p and clementi f absorption and tissue distribution of doxorubicin entrapped in liposomes following intravenous or intraperitoneal administration pharmacology morice p et al are nodal metastases in ovarian cancer chemoresistant lesions?